Showing results (21-30 of 142) with videos related to
Sort By:
Pageof 15
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Taxol and estramustine-induced modulation of human prostate cancer cell apoptosis via alteration in bcl-xL and bak expressionQ Y Liu, C A SteinCancer Research|May 15, 1988
Oligodeoxynucleotides as inhibitors of gene expression: a reviewC A Stein, J S CohenSeminars in Oncology|April 30, 2003
Modulation of the activity of Bcl-2 in Waldenstrom's macroglobulinemia using antisense oligonucleotidesGwen L Nichols, C A SteinNucleic Acids Research|October 11, 1994
Patterns of intracellular compartmentalization, trafficking and acidification of 5'-fluorescein labeled phosphodiester and phosphorothioate oligodeoxynucleotides in HL60 cellsJ L Tonkinson, C A SteinDrug Discovery Today. Technologies|July 2, 2014
A critical assessment of the potential of short interfering RNA therapeuticsC A Stein, J J RossiScience (New York, N.Y.)|August 20, 1993
Antisense oligonucleotides as therapeutic agents--is the bullet really magical?C A Stein, Y C ChengNucleic Acids Research|September 25, 1995
5'-Cholesteryl-phosphorothioate oligodeoxynucleotides: potent inhibition of methotrexate transport and antagonism of methotrexate toxicity in cells containing the reduced-folate carrierG B Henderson, C A SteinBioorganicheskaia Khimiia|September 1, 1993
[Design of a universal biotin-containing oligonucleotide diagnostic kit for detecting viroid plant diseases]I V Lebedeva, M G Ivanovskaia, T I Gurinovich, et al.Oligonucleotides|October 6, 2005
518A2 melanoma cells are protected by G3139 and other antineoplastic agents against the cytotoxic effects of DTICLuba Benimetskaya, Paul Miller, C A SteinSeminars in Oncology|December 13, 2005
Antisense strategies for oncogene inactivationC A Stein, Luba Benimetskaya, S ManiPageof 15